Gastrale MALT-Lymphome – ein Update

Das gastrale Marginalzonen-B-Zell-Lymphom des MALT (Mucosa-associated Lymphoid Tissue; MALT-Lymphom) ist das häufigste gastrointestinale Lymphom. Gegenüber anderen nodalen und extranodalen Lymphomen weist es spezifische Besonderheiten in Pathogenese, Diagnostik und Therapie auf. Dies hat den Umgang mit gastralen MALT-Lymphomen in den letzten 30 Jahren revolutioniert – das wesentliche Kennzeichen ist die konsequente Deeskalation der Therapie.

Schlüsselwörter

gastrales MALT-Lymphom - Pathogenese - Diagnostik - Therapie - klinisches Management

• Literatur

• 1 Fischbach W, Kestel W, Kirchner T. et al. Malignant lymphoma of the upper gastrointestinal tract. Results of a prospective study in 103 patients. Cancer 1992; 70: 1075-1080
• 2 Alaggio R, Amador C, Anagnostopoulos I. et al. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms”. Leukemia 2023; 37: 1944-1951
• 3 Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1983; 1: 1311-1315
• 4 Wyatt JI, Rathbone BJ. Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol 1998; 23 (Suppl. 142) 135-140
• 5 Stolte M, Eidt S. Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori?. J Clin Pathol 1989; 42: 1269-1271
• 6 Fischbach W, Eck M, Rosenwald A. From modern pathogenetic insights and molecular understanding to new deescalating therapeutic strategies in gastric MALT-lymphoma. Z Gastroenterol 2024; 62: 1952-1962
• 7 Doglioni C, Wotherspoon AC, Moschini A. et al. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992; 339: 834-835
• 8 Eck M, Schmaußer W, Haas R. et al. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997; 112: 1482-1486
• 9 Wotherspoon A, Ortiz-Hidalgo C, Falzon MR. et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-1176
• 10 Kolve M, Fischbach W, Greiner A. et al. Differences in endoscopic and clinicopathological features of primary and secondary gastric non-Hodgkin’s lymphoma. Gastrointest Endosc 1999; 49: 307-315
• 11 Ruskoné-Fourmestraux A, Fischbach W, Aleman BMP. et al. EGILS consensus report. Gastric extranodal marginal zone B cell lymphoma of MALT. Gut 2011; 60: 747-758
• 12 Fischbach W, Dragosics B, Koelve-Goebeler ME. et al. Primary gastric B-cell Lymphoma: Results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology 2000; 119: 1191-1202
• 13 Wotherspoon A, Doglioni C, Diss TC. et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577
• 14 Zullo A, Hassan C, Cristofari F. et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 2010; 8: 105-110
• 15 Fischbach W, Goebeler-Kolve ME, Dragosics B. et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication: experience from a large prospective series. Gut 2004; 53: 34-37
• 16 Wündisch T, Thiede C, Morgner A. et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005; 23: 1-7
• 17 Fischbach W, Bornschein J, Hoffmann JC. et al. Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol 2023; 61: 544-606
• 18 Fischbach W, Goebeler-Kolve M, Starostik P. et al. Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet 2002; 360: 547-548
• 19 Fischbach W, Goebeler ME, Ruskone-Fourmestraux A. et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy. Experience from a large international series. Gut 2007; 56: 1685-1687
• 20 Fischbach W, Dorlöchter C. Patients with gastric MALT lymphoma revealing persisting endoscopic abnormalities after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy. Z Gastroenterol 2019; 57: 1-7
• 21 Raderer M, Streubel B, Wöhrer S. et al. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut 2006; 55: 616-618
• 22 Zullo A, Hassan C, Ridola L. et al. Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients. A systematic Review. J Clin Gastroenterol 2013; 47: 824-827